Hanson Wade has made the decision to cancel this meeting. Please accept our apologies for any inconvenience or disappointment this may cause. Please register your interest here if you would like future updates on the meeting or topic.
Welcome to the Inaugural Autoimmune & Inflammatory Models Summit
Navigate Model Selection, Improve Translatability, Prepare for IND Submission
Despite remarkable advances in CIVM technology and animal models innovation throughout 2025, 90% of therapies still fall short of clinical success despite the amount of investment in the immunology and inflammation industry.
Selecting or developing poorly translatable models remains one of the biggest challenges, leading to misunderstood pathophysiology, incorrect candidate selection and unreliable PK/PD modelling.
The inaugural Autoimmune & Inflammatory Models Summit is the first industry-led meeting uniting pharma and biotech minds to share technical case studies and other insights to overcome model translatability.
Explore how leaders from like AbbVie, Pfizer, Seismic Therapeutics, and more, are advancing models for fast target and biomarker validation, efficacy and safety prediction, and eventually IND success.
The 2025 Speaker Faculty Included:
The 2025 Summit Partners:
